Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion

ClinicalTrials.gov ID: NCT03248440

Public ClinicalTrials.gov record NCT03248440. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Double-Masked, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion (SUN-131-03)

Study identification

NCT ID
NCT03248440
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Senju USA, Inc.
Industry
Enrollment
263 participants

Conditions and interventions

Conditions

Interventions

  • SUN-131 1.5% TDS Drug
  • Placebo TDS Drug

Drug

Eligibility (public fields only)

Age range
6 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 30, 2017
Primary completion
Aug 16, 2018
Completion
Aug 16, 2018
Last update posted
Aug 4, 2021

2017 – 2018

United States locations

U.S. sites
65
U.S. states
23
U.S. cities
59
Facility City State ZIP Site status
SUN-131-03 Investigational Site Chandler Arizona 85225
SUN-131-03 Investigational Site Prescott Arizona 86301
SUN-131-03 Investigational Site Sun City Arizona 85351
SUN-131-03 Investigational Site Glendale California 91204
SUN-131-03 Investigational Site Lancaster California 93534
SUN-131-03 Investigational Site Long Beach California 90805
SUN-131-03 Investigational Site Los Angeles California 90048
SUN-131-03 Investigational Site Mission Hills California 91345
SUN-131-03 Investigational Site Petaluma California 94954
SUN-131-03 Investigational Site Rancho Cordova California 95670
SUN-131-03 Investigational Site San Diego California 92115
SUN-131-03 Investigational Site Santa Ana California 92705
SUN-131-03 Investigational Site Colorado Springs Colorado 80907
SUN-131-03 Investigational Site Littleton Colorado 80120
SUN-131-03 Investigational Site Fort Myers Florida 33901
SUN-131-03 Investigational Site Largo Florida 33773
SUN-131-03 Investigational Site Maitland Florida 32751
SUN-131-03 Investigational Site Tamarac Florida 33321
SUN-131-03 Investigational Site Albany Georgia 31701
SUN-131-03 Investigational Site Morrow Georgia 30260
SUN-131-03 Investigational Site Roswell Georgia 30076
SUN-131-03 Investigational Site Chicago Ridge Illinois 60415
SUN-131-03 Investigational Site Glenview Illinois 60026
SUN-131-03 Investigational Site Hoffman Estates Illinois 60169
SUN-131-03 Investigational Site Lake Villa Illinois 60046
SUN-131-03 Investigational Site Leawood Kansas 66211
SUN-131-03 Investigational Site Shawnee Mission Kansas 66204
SUN-131-03 Investigational Site Lexington Kentucky 40509
SUN-131-03 Investigational Site Louisville Kentucky 40206
SUN-131-03 Investigational Site Saint Joseph Michigan 49085
SUN-131-03 Investigational Site Bloomington Minnesota 55420
SUN-131-03 Investigational Site Kansas City Missouri 64133
SUN-131-03 Investigational Site St Louis Missouri 63131
SUN-131-03 Investigational Site Washington Missouri 63090
SUN-131-03 Investigational Site Las Vegas Nevada 89119
SUN-131-03 Investigational Site Las Vegas Nevada 89123
SUN-131-03 Investigational Site Wantagh New York 11793
SUN-131-03 Investigational Site Asheville North Carolina 28803
SUN-131-03 Investigational Site Charlotte North Carolina 28210
SUN-131-03 Investigational Site High Point North Carolina 27262
SUN-131-03 Investigational Site Cincinnati Ohio 45236
SUN-131-03 Investigational Site Cincinnati Ohio 45247
SUN-131-03 Investigational Site Mason Ohio 45040
SUN-131-03 Investigational Site Lancaster Pennsylvania 17601
SUN-131-03 Investigational Site Lancaster Pennsylvania 19087
SUN-131-03 Investigational Site Philadelphia Pennsylvania 19148
SUN-131-03 Investigational Site Wayne Pennsylvania 19087
SUN-131-03 Investigational Site Florence South Carolina 29501
SUN-131-03 Investigational Site Rapid City South Dakota 57701
SUN-131-03 Investigational Site Chattanooga Tennessee 37411
SUN-131-03 Investigational Site Memphis Tennessee 38119
SUN-131-03 Investigational Site Nashville Tennessee 37215
SUN-131-03 Investigational Site Cedar Park Texas 78613
SUN-131-03 Investigational Site Houston Texas 77008
SUN-131-03 Investigational Site Houston Texas 77034
SUN-131-03 Investigational Site Houston Texas 77055
SUN-131-03 Investigational Site Lakeway Texas 78734
SUN-131-03 Investigational Site Mission Texas 78572
SUN-131-03 Investigational Site San Antonio Texas 78209
SUN-131-03 Investigational Site San Antonio Texas 78240
SUN-131-03 Investigational Site Salt Lake City Utah 84117
SUN-131-03 Investigational Site Exmore Virginia 23350
SUN-131-03 Investigational Site Falls Church Virginia 22046
SUN-131-03 Investigational Site Norfolk Virginia 23456
SUN-131-03 Investigational Site Racine Wisconsin 53405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03248440, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 4, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03248440 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →